<DOC>
	<DOC>NCT00535938</DOC>
	<brief_summary>The MOBILITY Project is a prospective, non-randomized, observational, multi-centre evaluation of Health Utility via the SF-12速 Health Survey Scores and the SF-6D in patients receiving BOTOX速 for therapeutic use.</brief_summary>
	<brief_title>MDs on Botox Utility (MOBILITY)</brief_title>
	<detailed_description />
	<mesh_term>Strabismus</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Blepharospasm</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patients who are eligible for BOTOX速 treatment deemed medically necessary by their physician Patient (and/or patient's authorized legal representative) should provide written informed consent; a patient under the age of 18 must review and sign the Patient Assent Form Patients at the age of or over 14 Patient is participating in a clinical trial for any BOTOX速 indication Patient with any contraindications to use botulinum toxin A</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>